High volume throwback to the breakout likely was a shakeout move.
Risk: 90 bps
You don't need to know what's going to happen next to make money ~Mark Douglas
Anything can happen ~Mark Douglas
Everyone wants a trading strategy that allows you to make 1 trade per day but still beat the market. Here are I explore how you could make one.
The Strategy: Gap & Go for Biotech Stocks
There is no point to reinvent the wheel so I took a highly popularized Gap & Go strategy. The “Gap & Go” is looking for stocks gap up from the previous day's close price with...
** investment opportunity - low risk - market capital > $1.4B **
The above 10-day chart could be discussed for hours there’s so much going on. Will try to keep it brief!
1) Price action has corrected over 91% without the help of stock splits. It is incredible to think folks were trading this stock 10x current prices as recently as November 2019.
2) A ‘great...
My first idea. ☺
TCDA is my long term investment. Within few month I will expect 7$ or more. But I plan to hold it about few years until it reach to 40$ (min 27$). In reality I didn't put stop loss. I pt risk to reward tool for calculation.
Any investment within 1 year will bring some profit but BUY at your own risk.
Do not use leverage.
Let's see.
Tricida Inc is a late-stage pharmaceutical company. It is focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal, or GI, tract. The primary area of focus is to slow the progression of chronic...
Tricida, Inc. is a pharmaceutical company. It focuses on the development and commercialization of its product, TRC101, a non-absorbed, orally-administered polymer drug designed to treat metabolic acidosis in patients with chronic kidney disease. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in South San Francisco, CA.
NASDAQ
